The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases

Background: While radiotherapy has been studied in the treatment of locally advanced pancreatic ductal adenocarcinoma (PDAC), few studies have analyzed the effects of radiotherapy on PDAC in patients with liver metastases. This study aimed to determine whether PDAC patients with liver metastases hav...

Full description

Bibliographic Details
Main Authors: Linxia Wu, Yuting Lu, Lei Chen, Xiaofei Yue, Chunyuan Cen, Chuansheng Zheng, Ping Han
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/10/625
_version_ 1827650780251815936
author Linxia Wu
Yuting Lu
Lei Chen
Xiaofei Yue
Chunyuan Cen
Chuansheng Zheng
Ping Han
author_facet Linxia Wu
Yuting Lu
Lei Chen
Xiaofei Yue
Chunyuan Cen
Chuansheng Zheng
Ping Han
author_sort Linxia Wu
collection DOAJ
description Background: While radiotherapy has been studied in the treatment of locally advanced pancreatic ductal adenocarcinoma (PDAC), few studies have analyzed the effects of radiotherapy on PDAC in patients with liver metastases. This study aimed to determine whether PDAC patients with liver metastases have improved survival after radiotherapy treatment. Methods: The data of 8535 patients who were diagnosed with PDAC with liver metastases between 2010 and 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Survival analysis and Cox proportional hazards regression analysis of cancer-specific mortality and overall survival were performed, and propensity score matching (PSM) was used to reduce selection bias. Results: After PSM, the median overall survival (mOS) and median cancer-specific survival (mCSS) in the radiotherapy group were longer than those in the nonradiotherapy group (OS: 6 months vs. 4 months; mCSS: 6 months vs. 5 months, both <i>p</i> < 0.05), respectively. The multivariate analysis showed that cancer-specific mortality rates were higher in the nonradiotherapy group than in the radiotherapy group (HR: 1.174, 95% CI: 1.035–1.333, <i>p</i> = 0.013). The Cox regression analysis according to subgroups showed that the survival benefits (OS and CSS) of radiotherapy were more significant in patients with tumor sizes greater than 4 cm (both <i>p</i> < 0.05). Conclusions: PDAC patients with liver metastases, particularly those with tumor sizes greater than 4 cm, have improved cancer-specific survival (CSS) rates after receiving radiotherapy.
first_indexed 2024-03-09T20:24:46Z
format Article
id doaj.art-eeab6e17ac2c4fcca0e3a59bd0a0699a
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T20:24:46Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-eeab6e17ac2c4fcca0e3a59bd0a0699a2023-11-23T23:41:16ZengMDPI AGCurrent Oncology1198-00521718-77292022-10-0129107912792410.3390/curroncol29100625The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver MetastasesLinxia Wu0Yuting Lu1Lei Chen2Xiaofei Yue3Chunyuan Cen4Chuansheng Zheng5Ping Han6Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, ChinaBackground: While radiotherapy has been studied in the treatment of locally advanced pancreatic ductal adenocarcinoma (PDAC), few studies have analyzed the effects of radiotherapy on PDAC in patients with liver metastases. This study aimed to determine whether PDAC patients with liver metastases have improved survival after radiotherapy treatment. Methods: The data of 8535 patients who were diagnosed with PDAC with liver metastases between 2010 and 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Survival analysis and Cox proportional hazards regression analysis of cancer-specific mortality and overall survival were performed, and propensity score matching (PSM) was used to reduce selection bias. Results: After PSM, the median overall survival (mOS) and median cancer-specific survival (mCSS) in the radiotherapy group were longer than those in the nonradiotherapy group (OS: 6 months vs. 4 months; mCSS: 6 months vs. 5 months, both <i>p</i> < 0.05), respectively. The multivariate analysis showed that cancer-specific mortality rates were higher in the nonradiotherapy group than in the radiotherapy group (HR: 1.174, 95% CI: 1.035–1.333, <i>p</i> = 0.013). The Cox regression analysis according to subgroups showed that the survival benefits (OS and CSS) of radiotherapy were more significant in patients with tumor sizes greater than 4 cm (both <i>p</i> < 0.05). Conclusions: PDAC patients with liver metastases, particularly those with tumor sizes greater than 4 cm, have improved cancer-specific survival (CSS) rates after receiving radiotherapy.https://www.mdpi.com/1718-7729/29/10/625pancreatic ductal adenocarcinomaliver metastasiscancer-specific survivalradiotherapyeffects
spellingShingle Linxia Wu
Yuting Lu
Lei Chen
Xiaofei Yue
Chunyuan Cen
Chuansheng Zheng
Ping Han
The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
Current Oncology
pancreatic ductal adenocarcinoma
liver metastasis
cancer-specific survival
radiotherapy
effects
title The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
title_full The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
title_fullStr The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
title_full_unstemmed The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
title_short The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
title_sort effects of radiotherapy on pancreatic ductal adenocarcinoma in patients with liver metastases
topic pancreatic ductal adenocarcinoma
liver metastasis
cancer-specific survival
radiotherapy
effects
url https://www.mdpi.com/1718-7729/29/10/625
work_keys_str_mv AT linxiawu theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT yutinglu theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT leichen theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT xiaofeiyue theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT chunyuancen theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT chuanshengzheng theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT pinghan theeffectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT linxiawu effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT yutinglu effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT leichen effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT xiaofeiyue effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT chunyuancen effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT chuanshengzheng effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases
AT pinghan effectsofradiotherapyonpancreaticductaladenocarcinomainpatientswithlivermetastases